Immunonutrition in experimental colitis: Beneficial effects of omega-3 fatty acids;Umunonutrição em colite experimental: Efeitos benéficos dos ácidos graxos ômega-3

Arquivos de Gastroenterologia

Volumn 39, Issue 1, 2002, Pages 48-54

  Campos, Fábio Guilherme ^a   Waitzberg, Dan L ^b   Logulo, Angela Flávia ^b   Torrinhas, Raquel Susana ^b   Teixeira, William Gemio Jacobsen ^b   Habr Gama, Angelita ^b  

^a NONE   (Brazil)

^b NONE

Author keywords

Colitis, ulcerative; Fat emulsion, intravenous; Fatty acids, omega 3; Inflammation mediators; Inflammatory bowel diseases; Lipids; Rats, Wistar

Indexed keywords

ACETIC ACID; FISH OIL; LIPID EMULSION; LIPOFUNDIN; LIPOVENOES; OMEGA 3 FATTY ACID; OMEGAVENOS; AUTACOID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CENTRAL VENOUS CATHETER; COLITIS; CONTROLLED STUDY; ENTERITIS; IMMUNONUTRITION; INFLAMMATION; INTESTINE ULCER; LIPID COMPOSITION; MACROPHAGE; MALE; NONHUMAN; NUTRITION; RAT; ULCERATIVE COLITIS; ANIMAL; PATHOLOGY; PHYSIOLOGY; WISTAR RAT;

ANIMALS; COLITIS; FAT EMULSIONS, INTRAVENOUS; FATTY ACIDS, OMEGA-3; INFLAMMATION MEDIATORS; MACROPHAGES; MALE; RATS; RATS, WISTAR;

EID: 0038746680     PISSN: 00042803     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0004-28032002000100009     Document Type: Article

References (48)

1. Alexander JW. Immunonutrition: the role of ω-3 fatty acids. Nutrition 1998;14:627-33.
2. Aslan AMD, Triadafilopoulos GMD. Fish oil fatty acid supplementation in active ulcerative colitis: a double-blind, placebo-controlled, crossover study. Am J Gastroenterol 1992;87:432-7.
3. Calder PC. Immunomodulatory and the anti-inflamatory effects of n-e polyunsaturated fatty acids. Proc Nutr Soc 1996;55:737-74.
4. Campbell JM, Fahey GC, Lichtensteiger CA, Demichele SJ, Garleb KA. All enteral formula containing fish oil, indigestible oligosaccharides, gum arabic and antioxidants affects plasma and colonic phospholipid fatty acid and prostaglandin profiles in pigs. J Nutr 1997;127:137-45.
5. Campos FG, Waitzberg DL, Plopper C, Terra RM, Habr-Gama A. Ácidos graxos de cadeia curta e doenças colo-retais. Rev Bras Nutr Clin 1998;13:276-85.
6. Carpentier YA, Simoens C, Siderova V, Vanweyenberg V, Eggerickx D, Deckelbaum RJ. Recent developments in lipid emulsions: relevance to intensive care. Nutrition 1997;13 Suppl:73-8.
7. Cukier C, Waitzberg DL, Soares SR, Logullo AF, Bacchi CE, Travassos VH, Saldiva PH, Torrinhas RS, Oliveira TS. Effect of glucidic and fat total parenteral nutrition on macrophage phagocytosis in rats. Rev Hosp Clin Fac Med São Paulo 1997;52:239-45.
8. Fürst P. New parenteral substrates in clinical nutrition. Part II. New substrates in lipid nutrition. Eur J Clin Nutr 1994;48:681-91.
9. Fürst P, Kuhn KS. Fish oil emulsions: what benefits can they bring? Clin Nutr 2000;19:7-14.
10. Gelas P, Cotte L, Poitevin-Later F, Pichard C, Leverve X, Barnoud D, Leclercq P, Touraine-Moulin F, Trépo C, Boulétreau P. Effect of parenteral medium- and long- chain triglycerides on lymphocytes subpopulations and functions in patients with acquired immunodeficiency syndrome: a prospective study. JPEN J Parenter Enteral Nutr 1998;22:67-71.
11. Greenfield SM, Green AT, Teare JP, Jenkins AP, Punchard NA, Ainley CC, Thompson RP. A randomized controlled study of evening primrose oil and fish oil in ulcerative colitis. Aliment Pharmacol Ther 1993;7:159-66.
12. Grimm H, Tibell A, Norrlind B, Blecher C, Wilker S, Schwemmle K. Immunoregulation by parenteral lipids: impact of the n-3 to n-6 fatty acid ratio. JPEN J Parent Enteral Nutr 1994;18:417-42.
13. Grimm H, Schott J, Schwemmle K. Development of an immuno-neutral lipid emulsion for optimal postoperative management of intensive care patients. Lingenbecks Arch Chir Kongressbd 1998;115:599-604.
14. Grimminger F, Führer D, Papavassilis C, Schlotzer E, Mayer K, Heuer K, Kiss L, Walmrath D, Kramer HJ, Seeger W. Influence of intravenous n-3 lipid supplementation on fatty acids profiles and lipid mediator generation in patients with severe ulcerative colitis. Eur J Clin Invest 1993;23:706-15.
15. Guarner F, Vilaseca J, Malagelada JR. Dietary manipulation in experimental inflammatory bowel disease. Agents Actions 1992;Spec No:C-104.
16. Habr-Gama A. Retocolite ulcerativa. In: Pinotti HW, editor. Tratado de clinica cirúrgica. São Paulo, Atheneu, 1994. p. 1169-84.
17. Hayashi N, Tashiro T, Yamamori H, Takagi K, Morishima Y, Otsubo Y, Sugiura T, Furukawa K, Nitta H, Nakajima N, Suzuki N, Ito I. Effect of intravenous ω-6 and ω-3 fat emulsion on nitrogen retention and protein kinetics in burned rats. Nutrition 1999;15:135-9.
18. Ikehata A, Hiwatashi N, Kinouchi Y, Yamazaki H, Kumagai Y, Ito K, Kayaba Y, Toyota T. Effect of intravenously infused eicosapentaenoic acid on the leukotriene generation in patients with active Crohn's disease. Am J Clin Nutr 1992;56:938-42.
19. Inui K, Fukuta Y, Ikeda A, Kameda H, Kokuba Y, Sato M. The effect of alphalinolenic acid-rich emulsion on fatty acid metabolism and leukotriene generation of the colon in a rat model with inflammatory bowel disease. Ann Nutr Metab 1996;40:175-82.
20. Inui K, Fukuta Y, Kameda H, Kokuba Y, Sato M. The nutrition effect of a-linolenic acid-rich emulsion with total parenteral nutrition in a rat model with inflammatory bowel disease. Ann Nutr Metab 1996;40:227-33.
21. Kinsella JE. Lipids, membrane receptors and enzymes: effects of dietary fatty acids. JPEN J Parent Enteral Nutr 1990;14 Suppl:200.
22. Lauritsen K, Laursen LS, Bukhave K, Rask-Madsen J. Effects of sulphasalazine and disodium azodisalicylate on colonic PGE2 concentrations determined by equilibrium in vivo dialysis of faeces in patients with ulcerative colitis and health controls. Gut 1984;25:1271-8.
23. Lauritsen K, Laursen LS, Bukhave K, Rask-Madsen J. Effect of topical 5-aminosalicylic acid (5-ASA) and prednisone on prostaglandin (PGE2) and leukotriene (LTB4) levels determined by equilibrium in vivo dialysis of rectum in relapsing ulcerative colitis. Gastroenterology 1986;91:837-44.
24. Loeschke K, Ueberschaer B, Pietsch A, Gruber E, Ewe K, Wiebecke B, Heldwein W, Lorenz R. N-3 fatty acids only delay early relapse of ulcerative colitis in remission. Dig Dis Sci 1996;41:2087-94.
25. Lorenz-Meyer H, Bauer P, Nicolay C, Schulz B, Purrmann J, Fleig WE, Scheurlen C, Koop I, Pudel V, Carr L. Omega-3 fatty acids and low carbohydrate diet for maintenance of remission in Crohn's disease. A randomized controlled multicenter trial. Scand J Gastroenterol 1996;31:778-85.
26. Lowe VC, Noronha-Blob L. The leucocyte recruitment inhibitor, NPC 15669 accelerates healing in acetic acid-induced colitis. Agents Actions 1993;39:80-2.
27. MacPherson BR, Pfeiffer CJ. Experimental production of diffuse colitis in rats. Digestion 1978;17:135-50.
28. Marotta F, Chui DH, Safran P, Rezakovic I, Zhong GG, Ideo G. Shark fin enriched diet prevents mucosal lipid abnormalities in experimental acute colitis. Digestion 1995;56:46-51.
29. Moraes RS. Indução da colite difusa pela instilação de ácido acético via retal: estudo experimental em ratos Sprague-Dawley [dissertação]. Curitiba: Universidade Federal do Paraná; 1987.
30. Moraes RS. Aspectos morfológicos da colite induzida pelo ácido acético a 10% e tratada com enemas de ácido 5-amino-2-hidroxibenzóico. Estudo experimental em ratos Sprague-Dawley [tese]. São Paulo: Escola Paulista de Medicina; 1989.
31. Morlion BJ, Torwesten E, Lessire A, Peskar BM, Fürst P, Puchstein C. The effect of parenteral fish oil on leukocyte membrane fatty acid composition and leukotriene synthesizing capacity in postoperative trauma. Metabolism 1996;45:1208-13.
32. Morlion BJ, Torwesten E, Wrenger K, Puchstein C, Fürst P. What is the optimum ω-3 to ω-6 fatty acid ratio of parenteral lipid emulsions in postoperative trauma? Clin Nutr 1997;16:49.
33. Nieto N, Fernandez MI, Torres MI, Rios A, Suarez MD, Gil A. Dietary monounsaturated n-3 and n-6 long-chain polyunsaturated fatty acids affected cellular antioxidant defense system in rats with experimental ulcerative colitis induced by trinitrobenzene sulfonic acid. Dig Dis Sci 1998;43:2676-87.
34. Noronha IL, Niemier Z, Ritz E, Waldherr R. Expression of cytokines and growth factors in renal diseases. Nephrol Dial Transplant 1995;10:775-86.
35. Pradelles P, Grassi J, MacLouf J. Enzyme immunoassays of eicosanoids using acetylcholine esterase as label: an alternative to radioimmunoassay. Anal Chem 1985;57:1170-3.
36. Roper RL, Phipps RP. Prostaglandin E2 regulation of the immune response. Adv Prostaglandin Thromboxane Leukot Res 1994;22:101-11.
37. Rutgeerts P. Medical therapy of inflammatory bowel disease. Digestion 1998;59:453-69.
38. Sartor RB. Pathogenesis and immune mechanisms of chronic inflammatory bowel diseases. Am J Gastroenterol 1997;92:5S-11S.
39. Schmidt EB, Dyerberg J. Omega-3 fatty acids. Current status in cardiovascular medicine. Drugs 1994;47:405-24.
40. Sharon P, Stenson WF. Enhanced synthesis of leukotriene B4 by colonic mucosa in inflammatory bowel disease. Gastroenterology 1984;86:453-60.
41. Sharon P, Stenson WF. Metabolism of arachidonic acid in acetic acid colitis in rats: similarity to human inflammatory bowel disease. Gastroenterology 1985;88:55-63.
42. Shoda R, Matsueda K, Yamato S, Umeda N. Therapeutic efficacy of N-3 polyunsaturated fatty acid in experimental Crohn's disease. J Gastroenterol 1995;30 Suppl 8:98-101.
43. Stenson WF, Cort D, Rodgers J, Burakoff R, DeSchryver-Kecskemeti K, Gramlich TL, Beeken W. Dietary supplementation with fish oil in ulcerative colitis. Ann Intern Med 1992;116:609-14.
44. Tashiro T, Yamamori H, Hayashi N, Sugiura T, Takagi K, Furukawa K, Nakajima N, Itoh I, Wakabayashi T, Ohba S, Akahane N. Effects of a newly developed fat emulsion containing eicosapentaenoic acid and docosahexaenoic acid on fatty acid profiles in rats. Nutrition 1998;14:372-5.
45. Teixeira MG, Habr-Gama A, Alcântara RSM, Brunetti-Netto C, Pinotti HW. Doença de Crohn: resultado do tratamento clínico em 121 pacientes. Rev Bras Coloproctol 1993;3:94-9.
46. Teixeira MG, Habr-Gama A, Takiguti C, Calache JE, Teixeira WG, Pinotti HW. Colonic Crohn's disease: results of treatment. Rev Hosp Clin Fac Med Sáo Paulo 1998;53:61-7.
47. Ulrich H, Pastores SM, Katz DP, Kvetan V. Parenteral use of medium-chain triglycerides: a reappraisal. Nutrition 1996;12:231-8.
48. Yeh SL, Chang KY, Huamg PC, Chen WJ. Effects of n-3 and n-6 fatty acids on plasma eicosanoids and liver antioxidant enzymes in rats receiving total parenteral nutrition. Nutrition 1997;13:32-6.